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Abstract 
Background 
Despite the relative ease with which breech presentation can be identified through ultrasound 
screening, the assessment of fetal presentation at term is often based on clinical examination 
only. Due to limitations in this approach, many women present in labour with an undiagnosed 
breech presentation, with increased risk of fetal morbidity and mortality. This study sought to 
determine the cost-effectiveness of universal ultrasound scanning for breech presentation 
near term (36 weeks of gestational age [wkGA]) in nulliparous women. 
Methods and findings 
The Pregnancy Outcome Prediction (POP) study was a prospective cohort study between 
January 14, 2008 and July 31, 2012, including 3879 nulliparous women who attended for a 
research screening ultrasound examination at 36 wkGA. Fetal presentation was assessed and 
compared for the groups with and without a clinically indicated ultrasound. Where breech 
presentation was detected, an external cephalic version (ECV) was routinely offered. If the 
ECV was unsuccessful or not performed, the women were offered either planned caesarean 
section at 39 weeks or attempted vaginal breech delivery. To compare the likelihood of 
different mode of deliveries and associated long-term health outcomes for universal 
ultrasound to current practice, a probabilistic economic simulation model was constructed. 
Parameter values were obtained from the POP study, and costs were mainly obtained from 
the English NHS. 
179 out of 3879 women (4.6%) were diagnosed with breech presentation at 36 weeks. For 
most women (96), there had been no prior suspicion of non-cephalic presentation. ECV was 
attempted for 84 (46.9%) women and was successful in 12 (success rate: 14.3%). Overall, 19 
of the 179 women delivered vaginally (10.6%), 110 delivered by elective Caesarean section 
(61.5%) and 50 delivered by emergency caesarean section (27.9%). There were no women 
with undiagnosed breech presentation in labour in the entire cohort. On average, 40 scans 
4 
 
were needed per detection of a previously undiagnosed breech presentation. The economic 
analysis indicated that, compared to current practice, universal late-pregnancy ultrasound 
would identify around 14,826 otherwise undiagnosed breech presentations across England 
annually. It would also reduce emergency caesarean section and vaginal breech deliveries by 
0.7 and 1.0 percentage points, respectively; around 4,196 and 6,061 deliveries across 
England annually. Universal ultrasound would also prevent 7.89 neonatal mortalities annually. 
The strategy would be cost-effective if fetal presentation could be assessed for £19.80 or less 
per woman. Limitations to this study included that fetal presentation was revealed to all 
women, and that the health economic analysis may be altered by parity. 
Conclusions According to our estimates, universal late pregnancy ultrasound in nulliparous 
women: (1) would virtually eliminate undiagnosed breech presentation, (2) would be expected 
to reduce fetal mortality in breech presentation, and (3) would be cost-effective if fetal 
presentation could be assessed for less than £19.8 per woman. 
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Author summary 
Why Was This Study Done? 
 Risks of complications at delivery are higher for babies that are in a breech position, 
but sometimes breech presentation is not discovered until the time of birth. 
 Ultrasound screening could be used to detect breech presentation before birth and 
lower the risk of complications, but would be associated with additional costs. 
 It is uncertain if offering ultrasound screening to every pregnancy is cost-effective. 
What Did the Researchers Do and Find? 
 This study recorded the birth outcomes of pregnancies that were all screened using 
ultrasound. 
 Economic modelling and simulation was used to compare these outcomes with those 
if ultrasound screening had not been used. 
 Modelling demonstrated that ultrasound screening would lower the risk of breech 
delivery, and as a result reduce emergency Caesarean sections and the baby’s risk 
of death. 
What Do These Findings Mean? 
 Offering ultrasound screening to every pregnancy would improve the health of 
mothers and babies nationwide. 
 Whether the health improvements are enough to justify the increased cost of 
ultrasound screening is still uncertain, mainly because the cost of ultrasound 
screening for presentation alone is unknown. 
 If ultrasound screening could be provided sufficiently inexpensive, for example by 
being used during standard midwife appointments, routinely offering ultrasound 
screening would be worthwhile. 
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Introduction 
Undiagnosed breech presentation in labour increases the risk of perinatal morbidity and 
mortality and represents a challenge for obstetric management. The incidence of breech 
presentation at term is around 3-4%,[1-3] and fewer than 10% of fetuses who are breech at 
term revert spontaneously to a vertex presentation.[4] Although breech presentation is easy 
to detect through ultrasound screening, many women go into labour with an undetected breech 
presentation.[5] The majority of these women will deliver through emergency Caesarean 
section, which has high costs and increases risk of morbidity and mortality for both mother 
and child. 
In current practice, fetal presentation is routinely assessed by palpation of the maternal 
abdomen by a midwife, obstetrician or general practitioner. The sensitivity of abdominal 
palpation varies between studies (range: 57-70%), and depends on the skill and experience 
of the practitioner.[6,7] There is currently no guidance on what is considered an acceptable 
false negative rate when screening for breech presentation using abdominal palpation. In 
contrast, ultrasound examination provides a quick and safe method of accurately identifying 
fetal presentation. 
Effective interventions exist for the care of women who have breech presentation diagnosed 
near term. The Royal College of Obstetricians and Gynaecologists recommends “that all 
women with an uncomplicated breech presentation at term should be offered External 
Cephalic Version (ECV)”.[2] The rationale for this is to reduce the incidence of breech 
presentation at term and avoid the risks of vaginal breech birth or Caesarean section. The 
success rate of ECV is considered to be approximately 50%,[2,8,9] but it differs greatly 
between nulliparous and parous women (34% and 66% respectively).[9] ECV is overall safe 
with less than 1% risk to the fetus and even smaller risk to the mother;[10] despite this a 
significant number of women decline ECV for various reasons.[11] Should ECV be declined, 
or fail, generally women are offered delivery by planned (elective) caesarean section, as there 
is level 1 evidence of reduced risk of perinatal death and severe morbidity compared with 
7 
 
attempting vaginal breech birth, and it is also associated with lower costs.[3,12,13] However, 
some women may still opt for an attempt at vaginal breech birth if they prioritise non-
intervention over managing the relatively small absolute risks of a severe adverse event.[1,14]  
We sought to assess the cost-effectiveness of universal late pregnancy ultrasound 
presentation scan for nulliparous women. We used data from the Pregnancy Outcome 
Prediction (POP) study, a prospective cohort study of >4000 nulliparous women, which 
included an ultrasound scan at 36 weeks of gestational age (wkGA).[15] Here, we report the 
outcomes for pregnant nulliparous women with breech presentation in the study, and use 
these data to perform a cost-effectiveness analysis of universal ultrasound as a screening test 
for breech presentation. 
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Methods 
Study design 
The POP study was a prospective cohort study of nulliparous women conducted at the Rosie 
Hospital, Cambridge (UK) between January 14, 2008 and July 31, 2012, and the study has 
been described in detail elsewhere.[15-17] Ethical approval for the study was obtained from 
the Cambridgeshire 2 Research Ethics Committee (reference 07/H0308/163) and all 
participants provided informed consent in writing. Participation in the POP study involved serial 
phlebotomy and ultrasound at ~12wkGA, ~20wkGA, ~28wkGA and ~36wkGA.[18] The 
outcome of pregnancy was obtained by individual review of all case records by research 
midwives and by linkage to the hospital’s electronic databases of ultrasonography, 
biochemical testing, delivery data and neonatal care data. The research ultrasound at 36wkGA 
was performed by sonographers and included presentation, biometry, uteroplacental Doppler 
and placental location. The ultrasound findings were blinded except in cases of breech 
presentation, low lying placenta or fetal concerns such as newly diagnosed fetal anomaly, and 
an amniotic fluid index <5cm. This study was not prospectively defined in the POP Study 
protocol paper[16], but required no further data collection. 
If the fetus was in a breech presentation at 36wkGA, women were counselled by a member of 
the medical team. In line with NICE guidelines, external cephalic version (ECV) was routinely 
offered unless there was a clinical indication which contra-indicated the procedure, e.g. 
reduced amniotic fluid volume (AFI <5cm).[18] ECV was performed by one of five obstetric 
consultants in the unit between 36-38 wkGA, patients were scanned before the procedure to 
confirm presentation and it was performed with ultrasound assessment; 0.25mg terbutaline 
SC was given prior to the procedure at the discretion of the clinician. If women refused ECV 
or the procedure failed, the options of vaginal breech delivery and elective caesarean section 
were discussed and documented. The local guideline for management of breech presentation, 
including selection criteria for vaginal breech delivery, was based upon recommendations from 
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the RCOG.[1] We extracted information about ECV from case records that were individually 
reviewed by research midwives. Finally, we obtained delivery related information from our 
hospital electronic database (Protos; iSoft, Banbury, UK). 
Fetal outcomes included mode of delivery, birth weight, and gestational age at delivery. We 
used the UK population reference for birthweight, with the 10th and 90th percentile cut-offs for 
small and large for gestational age, respectively; the centiles were adjusted for sex and 
gestational age.[19] Maternal age was defined as age at recruitment. Smoking status, racial 
ancestry, alcohol consumption and BMI were taken from data recorded at the booking 
assessment by the community midwife. Socio-economic status was quantified using the Index 
of Multiple deprivation (IMD) 2007, which is based on census data from the area in the 
mother’s postcode.[20] Ethical approval for the study was obtained from the Cambridgeshire 
2 Research Ethics Committee (reference 07/H0308/163) and all participants provided 
informed consent in writing. 
 This study is reported as per the Strengthening the Reporting of Observational Studies in 
Epidemiology (STROBE) guideline. 
Statistical analysis 
Data are presented as median (inter-quartile range) or n (%), as appropriate. P-values are 
reported for the difference between groups calculated using the two-sample Wilcox rank-sum 
(Mann-Whitney) test for continuous variables and the Pearson Chi-square test for categorical 
variables, with trend tests where appropriate. Comparisons were performed using Stata 
(version 15.1). Missing values were included in the presentation of patient characteristics and 
outcomes, but excluded from the economic analysis and estimation of parameters. 
Economic model and analysis 
To evaluate the cost-effectiveness of routinely offering late pregnancy presentation scan, a 
decision-tree simulation model was constructed using R (version 3.4.1).[21-24] The time 
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horizon of the economic analysis was from the ultrasound scan (36wkGA) to infant lifetime, 
and costs were from the perspective of the English NHS. Costs for modes of delivery were 
obtained from NHS reference costs;[25] since these do not list a separate cost for vaginal 
breech delivery, we assumed that the cost ratio between vaginal breech and elective 
Caesarean section deliveries was the same as in another study (see supporting information, 
S1 Text).[12]  
The population of interest is unselected nulliparous women The model compares the 
outcomes at birth for two strategies: ‘universal ultrasound’ and ‘selective ultrasound’ (Fig 1). 
For universal ultrasound we assumed that all breech presentations at the time of scanning 
would be detected (i.e. assumed 100% sensitivity and specificity for the test). For selective 
ultrasound, the breech presentation was diagnosed either clinically (by abdominal palpation 
followed by ultrasound for confirmation) or as an incidental finding during a scan for a different 
indication. These assumptions were based upon current practice and derived from the POP 
study. 
Fig 1. Simulation model structure. 
Structure of economic simulation model. ‘Universal ultrasound’ strategy starts in Model A, and patients with 
breech presentation enter Model C. ‘Selective ultrasound’, i.e. no routine ultrasound, starts in Model B, and only 
those with a detected breech presentation enters Model C. The letter-number codes for each node is equivalent 
to the codes in Table 1. ELCS = Elective caesarean section; EMCS = Emergency caesarean section. 
Compared to a standard antenatal ultrasound where, typically, multiple measurements are 
made, an ultrasound scan for fetal presentation alone is technically simple. We theorized that 
such a scan could be provided by an attending midwife in conjunction with a standard 
antenatal visit in primary care, using basic ultrasound equipment. Since a specific unit cost for 
a scan for fetal presentation alone is not included in the national schedule of reference 
costs[25], we estimated the cost of ultrasound to include the midwife’s time, the cost of 
equipment and room. More details are presented in the supporting information, S1 Text. The 
cost of ECV was obtained from James et al.,[26] and converted to 2017 price level using the 
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Hospital & Community Health Services (HCHS) index.[27] The probability of ECV uptake and 
success rate, as well as mode of delivery were obtained from the POP study. All model inputs 
are presented in Table 1 and S1 Table, and the calculation of cost inputs is shown in 
supporting information, S1 Text. 
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Table 1: Inputs for costs and probabilities for the economic model 
Costs Costs Source 
Ultrasound scanning 20.7 Expert opinion * 
ECV 297.4 James et al. (2001)[26] † 
CV delivery 2297.3 NHS Reference costs 2015-16[25] ‡ 
Elective caesarean delivery 3438.1 NHS Reference costs 2015-16[25] ‡ 
Emergency caesarean delivery 4553.4 NHS Reference costs 2015-16[25] ‡ 
VB delivery 3999.7 Expert opinion * 
Probabilities Alpha Beta Mean Node Source 
Breech prevalence at ~36wkGA 179 3700 0.046 A1 & B1 POP study 
ECV attempted 84 93 0.475 C1 POP study 
Detection without ultrasound 79 96 0.451 B3 POP study 
Successful ECV 12 72 0.143 C2 POP study 
SRC (ECV not attempted) 21 72 0.226 C3 POP study 
SRB 1 11 0.083 C4 POP study 
SRC (failed ECV) 3 127 0.023 C5 Ben-Meir et al.[28] § 
Mode of delivery CV ELCS EMCS VB Node Source 
No breech 2813 141 735 0 A2 & B2 POP study 
Cephalic (successful ECV) 8 0 3 0 C8 POP study 
Cephalic (spontaneous reversion) 11 1 9 0 C6 & C10 POP study 
Breech (ECV not attempted) 0 52 20 0 C7 POP study 
Breech (Unsuccessful ECV) 0 54 18 0 C11 POP study 
Breech (spontaneous reversion) 0 0 15 11 C9 Leung et al.[5]  
Undetected breech 0 0 15 11 B4 Leung et al.[5]  
 
Costs given per unit/episode. For probabilities, Alpha represent case of event and Beta case of no event. Mode of delivery 
shows input values for Dirichlet distribution. Node refers to the chance nodes in Fig 1.  
CV = Cephalic Vaginal; ELCS = Elective caesarean section; EMCS = Emergency caesarean section; IDR = Incidental detection 
rate; SRB = Spontaneous reversion to breech; SRC = Spontaneous reversion to cephalic; VB = Vaginal breech 
* Details on how this value was estimated is provided as supporting information, S1 Text. 
 
† Cost for ECV (high staff cost), converted to 2017 price level using the Hospital & Community Health Services (HCHS) 
index.[27]  
‡ Weighted average of all complication levels (Total HRG’s) 
§ Due to the small sample size for these parameters in the POP study, the model used inputs for mode of delivery for 
undetected breech instead. 
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The end-state of the decision-tree was the mode of delivery, which was either vaginal, elective 
Caesarean section (ELCS), or emergency Caesarean section (EMCS). Delivery could be 
either cephalic or breech. Emergency Caesarean section could be either due to previously 
undiagnosed breech presentation, or for other reasons. All cases of breech could 
spontaneously revert to cephalic presentation. However, we assumed the probability of this to 
be lower if ECV had been attempted and failed.[28] If ECV was successful, a reversion back 
to breech presentation was possible. It is currently unclear whether the probability of mode of 
delivery varies depending on whether cephalic presentation is the result of successful ECV or 
spontaneous reversion,[2,10,29-31] but we assumed that the probabilities differed. 
Long-term health outcomes were modelled based upon the mortality risk associated with each 
mode of delivery (MOD). The risk of neonatal mortality was taken from the RCOG guidelines. 
For breech presentation, these risks were 0.05% for delivery through ELCS, and 0.20% for 
vaginal delivery. The risk of neonatal mortality for cephalic presentation with vaginal delivery 
was 0.10%.[1] There were no randomized clinical trials that allowed us to compare the 
outcomes of ELCS vs. vaginal delivery for uncomplicated pregnancies with cephalic 
presentation, however, most observational studies found no significant difference in neonatal 
mortality and serious morbidity between the two modes.[32-34] For this reason, we assumed 
the mortality risk for cephalic vaginal and ELCS deliveries to be identical. We also assumed 
that emergency Caesarean section (EMCS) would have the same mortality rate as ELCS, 
both for cephalic and breech deliveries. Studies have found that the mode of delivery for 
breech presentation affects the risk of serious neonatal morbidity in the short term, but not in 
the long term.[1,3,35] For this reason, we focused the economic analysis on the effect from 
mortality only. The average lifetime QALYs per member of the UK population was estimated 
using data on quality of life from Euroqol, weighted by longevity indexes from ONS.[36,37] 
Using the annual discount rate of 3.5% as recommended by NICE, the net present value for 
the average lifetime QALYs at birth was 24.3.[38]  
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The model was probabilistic, capturing how uncertainty in the input parameters affected the 
outputs by allowing each parameter to vary according to its distribution. Binary and 
multivariable outcomes were modelled using the beta and the Dirichlet distributions, 
respectively.[39] Probabilities of events were calculated from the POP study and presented in 
Table 1. On top of the probabilistic sensitivity analysis, the sensitivity of individual parameters 
was also explored through one-way sensitivity analyses modifying probabilities by +/- 1 
percentage point, and costs by +/- £10, to see which parameters had the greatest impact on 
cost-effectiveness estimates. 
Total costs depended on the distribution of mode of delivery, the number of expected 
mortalities, and the cost of ultrasound scanning and ECV. Nationwide costs for each screening 
strategy were calculated for 585,489 deliveries, i.e. the number of births in England 2016-17, 
assuming 92% occur after 36wkGA.[15,40] Model parameters were sampled from their 
respective distributions in a Probabilistic Sensitivity Analysis (PSA) of 100,000 simulations for 
each strategy. To determine cost-effectiveness, we used two different willingness-to-pay 
thresholds, £20,000 and £30, 000.[38] A copy of the model code is available from the 
corresponding author (EW) upon request.  
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Results 
Recruitment to the POP study cohort is shown in Fig 2, and has been previously described.[17] 
Information about presentation at the 36-week scan was available for 3879 women who 
delivered at the Rosie Hospital, Cambridge, UK; 179 of these had a breech presentation. 
Figure 2: Patient recruitment. 
Schedule of patient recruitment in the POP study, shown by fetal presentation. 
We compared maternal and fetal characteristics of the 179 women with breech presentation 
at 36 weeks to the women with a cephalic presentation (Table 2). Women diagnosed with 
breech presentation were on average a year older than women with a cephalic presentation, 
but other maternal characteristics did not differ. The babies of women diagnosed breech were 
smaller and born earlier but their birth weight centile and the proportions of SGA or LGA were 
not markedly different. There were no differences in maternal BMI between the groups. As 
expected, women with breech presentation were more likely to deliver by elective or 
emergency Caesarean section. 
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Table 2: Characteristics and delivery outcomes in the POP study by presentation at 36 
weeks.  
Characteristics Breech (N=179) Cephalic (N=3,700) P-value  
Maternal    
   Age (years) 31 (28 - 34) 30 (27 - 33) 0.002 
   Age stopped FTE  (years) 21 (18 - 23) 21 (18 - 23) 0.19 
        Missing 5 (3%) 105 (3%)  
   Racial ancestry    
        White European     172 (96%) 3437 (93%) 0.38 
        Missing 0 (0%) 66 (2%)  
   Alcohol consumption 7 (4%) 172 (5%) 0.65 
        Missing 0 (0%) 1 (<0.1%)  
   Smoker 4 (2%) 179 (5%) 0.11 
   BMI, kg/m2 24 (22 - 27) 24 (22 - 27) 0.69 
        Missing 0 (0%) 1 (<0.1%)  
   Deprivation quartile   0.08 
        1 (lowest) 46 (26%) 899 (24%)  
        2 53 (30%) 873 (24%)  
        3 39 (22%) 886 (24%)  
        4 (highest)  33 (18%) 892 (24%)  
        Missing 8 (4%) 150 (4%)   
Fetal or neonatal    
   Female sex 96 (54%) 1841 (50%) 0.31 
        Missing 0 (0%) 1 (<0.1%)  
   Birth weight (grams) 3310 (2995 – 3560) 3445 (3145 – 3750) <0.001 
   Gestational age (weeks) 39.1 (38.7 – 39.7) 40.4 (39.4 – 41.3) <0.001 
   Birth weight centile     49 (25 – 70) 44 (24 – 66) 0.22 
   Birth weight centile category   0.32 
        SGA 12 (7%) 332 (9%)  
        AGA 158 (88%) 3199 (86%)  
        LGA 9 (5%) 168 (5%)  
        Missing 0 (0%) 1 (<0.1%)   
Mode of delivery   <0.001 
   Spontaneous vaginal cephalic 11 (6.1%) 1885 (50.9%)  
   Instrumental vaginal cephalic 8 (4.5%) 928 (25.1%)  
   Elective caesarean section 110 (61.5%) 141 (3.8%)  
   Emergency caesarean section 50 (27.9%) 735 (19.9%)  
   Missing 0 (0%) 11 (0.3%)   
 
Statistics are presented as n (%) for binary outcomes, and median (inter-quartile range) for continuous variables. The 
"Missing" category was not included in statistical tests. For variables without a "Missing" category, data were 100% 
complete. P-values are reported for the difference between groups using the two-sample Wilcox rank-sum test for 
continuous variables and the Pearson Chi-square test for categorical variables, with trend test as appropriate (i.e. for 
deprivation quartile and birth weight centile category). 
FTE= full time education; BMI= body mass index; SGA, AGA and LGA denotes small, average and large for gestational age, 
respectively. 
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Breech presentation was suspected before the 36wkGA scan for 79 (44.1%) of the women 
with breech presentation through abdominal palpation by the midwife or doctor; out of these, 
27 had a clinically indicated scan between 32-36 weeks in which the presentation was 
reported. For 96 women, the breech presentation was unsuspected before the 36-week scan. 
Information on suspected breech position was missing for 4 women. There were no 
differences in BMI between the 79 women with suspected breech and the 96 women 
misdiagnosed as cephalic prior to the scan (median BMI was 24 in both groups, Wilcoxon rank 
sum test p=0.31). 
Mode of delivery by external cephalic version (ECV) status is shown in Table 3. ECV was 
performed for 84 women, declined by 45 women, and unsuitable for 23; contraindications 
included low AFI at screening (18 women), uterine abnormalities (2), and other reasons (3). 
For 25 women, an ECV was never performed despite consent; 17 babies turned 
spontaneously, 6 had reduced AFI on the day of the ECV, and 2 went into labour before ECV. 
When performed, ECV was successful for 12 women; in one case, the baby later reverted to 
breech presentation before delivery. Information on ECV uptake was missing for 2 women. 
Fetal presentation and ECV status in the structure of the economic model is shown in 
supporting information, S1 Fig. 
Table 3: Mode of delivery by presentation and response to ECV for POP study 
participants with breech presentation at 36-week scan (n = 179). 
 
ECV status Vaginal ELCS EMCS Total 
ECV successful 8 1 3 12 
ECV unsuccessful 0 54 18 72 
ECV not offered * 1 17 5 23 
ECV discussed but declined 1 32 12 45 
ECV accepted but not performed † 9 5 11 25 
Missing 0 1 1 2 
Total 19 110 50 179 
 
ELCS = Elective caesarean section; EMCS = Emergency caesarean section 
* 18 women were contraindicated due to low AFI at screening, 2 for uterine abnormalities, and 3 for other reasons 
 † 17 babies turned spontaneously, 6 had reduced AFI on the day of the ECV, and 2 went into labour before ECV 
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The results from the economic analysis are presented in Table 4. On average, universal 
ultrasound resulted in an absolute decrease in breech deliveries by 0.39%. It also led to fewer 
vaginal breech deliveries (absolute decrease by 1.04%), and overall EMCS deliveries (0.72%) 
than selective ultrasound, but increased overall deliveries through ELCS (1.51%). Resulting 
from the more favourable distribution of mode of delivery, the average risk of mortality fell by 
0.0013%. On average, 40 women had to be scanned to identify one previously unsuspected 
breech presentation (95% Credibility Interval (CrI): 33 to 49); across England, this would mean 
that 14,826 (95% CrI: 12.048 – 17,883) unidentified breech presentations could be avoided 
annually. 
Table 4: Simulated cost and mode of delivery distribution for universal ultrasound and 
no ultrasound 
  
Universal 
ultrasound 
Selective 
ultrasound 
Difference 
(per patient) 
Difference 
(Total population) 
Total cost 2956.59 2949.30 7.29 4,268,004  
  Screening cost 20.70 0.43 20.27 11,867,159  
  ECV cost 6.52 2.94 3.57 2,093,048  
  Delivery cost 2927.78 2944.31 -16.53 -9,679,396  
  Mortality cost 1.59 1.62 -0.02 -12,806  
Vaginal cephalic 0.6850 0.6826 0.0024 1,399  
ELCS cephalic 0.0442 0.0441 0.0001 84  
EMCS cephalic 0.2321 0.2305 0.0016 918  
Vaginal breech 0.0007 0.0110 -0.0104 -6,061  
ELCS breech 0.0273 0.0123 0.0150 8,774  
EMCS breech 0.0107 0.0194 -0.0087 -5,115  
Total mortality 0.000982 0.000995 -0.000013 -7.89  
Total QALY 24.27615 24.27582 0.000327 191.73 
 
Costs (£) are presented per patient, except in column for ‘Total population’ (n = 585,489). 
CV = Cephalic vaginal; ECV = External cephalic version; ELCS = Elective caesarean section; EMCS = Emergency caesarean 
section; QALY = Quality-adjusted life years; VB = Vaginal breech. 
The expected per person cost of universal ultrasound was £2,957 (95% Credibility Interval 
(CrI): £2,922 - £2,991), compared to £2,949 (95% CrI: £2,915 - £2,984) from selective 
ultrasound, a cost increase of £7.29 (95% CrI: 2.41 – 11.61). Across England, this means that 
universal ultrasound would cost £4.27M more annually than current practice. The increase 
stems from higher costs of ultrasound scan (£20.3 per person) and ECV (£3.6 per person), 
but is partly offset by the lower delivery costs (-£16.5 per person). The distribution of 
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differences in costs between the two strategies is shown as supporting information, S2 Fig. 
The simulation shows that universal ultrasound would on average increase the number of total 
ELCS deliveries by 8,858 (95% CrI: 7,662 – 10,068), but decrease the number of EMCS and 
vaginal breech deliveries by 4,196 (95% CrI: 2,779 – 5,603) and 6,061 (95% CrI: 6,617 – 
8,670) per year, respectively. 
The long-term health outcomes are presented in Table 4. Nationwide, universal ultrasound 
would be expected to lower mortality by 7.89 cases annually (95% CrI: 3.71, 12.7). After 
discounting, this means that universal ultrasound would be expected to yield 192 QALYs 
annually (95% CrI: 90, 308). The cost-effectiveness of universal ultrasound depends on the 
value assigned to these QALYs. The incremental cost-effectiveness ratio was £23,611 (95% 
CrI: 8,184, 44,851), which is of borderline cost-effectiveness (given NICE’s willingness to pay 
of £20,000 to £30,000).[38] The number needed to scan per prevented mortality was 74,204 
(95% CrI: 46,124 – 157,642). 
One-way sensitivity analysis showed that the probability parameter with the greatest impact 
upon the cost-effectiveness of universal ultrasound was the prevalence of breech: increasing 
this parameter by 1 percentage point was associated with a relative reduction of costs for 
universal ultrasound by £3.07. The results were less sensitive to the ECV success rate, an 
increase by 1 percentage point led to a relative reduction in the cost of universal ultrasound 
by £0.12. The most important cost parameter was the unit cost of ultrasound scan, an increase 
in this parameter by £10 led to a relative increase for universal ultrasound by £9.79 (see 
supporting information, S3 Fig). Keeping all other parameters equal, universal ultrasound 
would be cost-effective if ultrasound scanning could be provided for less than £19.80 or £23.10 
per mother, for a willingness-to-pay threshold of £20,000 or £30,000, respectively. For 
universal ultrasound to be cost-saving, scans would need to cost less than £12.90 per mother.  
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Discussion 
In a prospective cohort study of >3,800 women having first pregnancies, a presentation scan 
at ~36wkGA identified the 4.6% of women who had a fetus presenting by the breech and for 
more than half of these, breech presentation had not previously been clinically suspected. The 
majority of these women were ultimately delivered by planned Caesarean section, some 
experienced labour before their scheduled date and were delivered by emergency Caesarean 
section, and a small proportion had a cephalic vaginal delivery following either spontaneous 
or external cephalic version. No woman in the cohort had a vaginal breech delivery, or 
experienced an intrapartum Caesarean for undiagnosed breech. The low uptake of vaginal 
breech birth is likely to reflect the fact that this is a nulliparous population and it is generally 
accepted that the risks associated with vaginal breech delivery are lower in women who have 
had a previous normal birth.  
Our economic analysis suggest that a universal late pregnancy presentation scan would 
decrease the number of fetal mortalities associated with breech presentation, and that this is 
of borderline cost-effectiveness, costing an estimated £23,611 per QALY gained. The key 
driver of cost-effectiveness is the cost of the scan itself. In the absence of a specific national 
unit cost, we have identified the maximum cost at which it would be cost-effective. This is 
£19.80 per scan to yield an ICER of £20,000 per QALY, and £23.10 at £30,000. These unit 
costs may be possible if assessment of presentation could be performed as part of a routine 
antenatal visit. Portable ultrasound systems adequate for presentation scans are available at 
low cost, and a presentation scan is technically quite simple, so the required level of skill could 
be acquired by a large cadre of midwives. This would result in a small fraction of the costs 
associated with a trained ultra-sonographer performing a scan in a dedicated space using a 
high specification machine. If universal ultrasound could be provided for less than £12.90 per 
scan, the policy would also be cost-saving. 
Our sensitivity analysis shows that the unit cost of ultrasound scans and the prevalence of 
breech presentation were by far the biggest determinants of the cost and cost-effectiveness 
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of universal ultrasound. The detection rate with abdominal palpation (i.e. for selective 
ultrasound) is the most important parameter aside from these. By contrast, the costs, attempt 
and success rates for external cephalic version (ECV) have modest impact upon the choice 
of scanning strategy. It appears that the main short-term cost benefit from late-pregnancy 
screening lies in the possibility of scheduling elective caesarean sections when breech 
presentation is detected, rather than turning the baby into a cephalic position. 
This analysis may have underestimated the health benefits of universal late pregnancy 
ultrasound. In the absence of suitable data on long-term outcomes by mode of delivery and 
fetal presentation, we made the simplifying assumption that mortality rates were equal for 
elective and emergency caesarean sections. Relaxing this assumption would likely favour 
universal ultrasound, as this strategy would reduce emergency Caesarean sections and these 
are associated with higher risks of adverse outcomes than elective Caesarean sections;[41-
44] on top of health benefits, this may also reduce long-term NHS costs. It is also possible that 
an emergency Caesarean section for a known breech presentation is less expensive and has 
better health outcomes than one where breech is detected intrapartum, although lack of 
separate data for these two scenarios prevented us from pursuing this analysis further. 
Our analysis shows that universal late pregnancy ultrasound screening would increase total 
number of Caesarean sections. Evidence suggests that caesarean delivery may have long-
term consequences on the health of the child (increased risk of asthma and obesity), the 
mother (reduced risk of pelvic organ prolapse and increased risk of subfertility) and future 
pregnancies (increased risk of placenta previa and stillbirth).[45,46] There is no evidence that 
these are related to the type of the Caesarean section (elective vs emergency).[45,46] Our 
economic modelling has not been able to capture these complex effects due to the model’s 
endpoints, and the focus on the current pregnancy only. However, accounting for these 
effects, it seems plausible that universal late pregnancy ultrasound would be more favourable 
for mothers than children or future pregnancies. 
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Our results are also driven by vaginal delivery yielding worse long-term health outcomes than 
elective caesarean section (ELCS) for breech presentation.[1] However, even though the rate 
of vaginal breech birth declined after the Term Breech Study, in many cases the outcomes 
are not inferior to that of ELCS, and the RCOG guidelines states that vaginal breech delivery 
may be attempted following careful selection and counselling.[1,3,47] It is hard to assess how 
an increase in vaginal breech delivery would affect the cost-effectiveness of universal 
ultrasound; whilst decreased mortality risk from vaginal breech delivery would decrease the 
importance of knowing the fetal presentation, universal screening would facilitate selection for 
attempted vaginal breech delivery. 
One limitation of this study is that fetal presentation was revealed to all women in the POP 
study. Consequently, this study cannot say what would have happened without routine 
screening. However, we felt that it was appropriate to reveal the presentation at the time of 
the 36wkGA scan as there is level 1 evidence that planned caesarean delivery reduces the 
risk of perinatal morbidity and mortality in the context of breech presentation at term.[44] 
Another weakness was that the study was being undertaken in a single centre only, and that 
the sample size was too small to avoid substantial parameter uncertainty for rare events. 
Moreover, less than half of all breech presentations in the POP study were detected by 
abdominal palpation. It is unclear whether the detection rates were affected by midwives 
knowing that the women were part of the POP study and hence would receive an ultrasound 
scan at 36wkGA. 
The prevalence of breech presentation in this study (4.6%) appears higher than the 3-4% that 
is often reported in literature.[1] However, this study is unique in that it reports the prevalence 
at the time of ultrasound scanning, ~36wkGA. Taking into account the number of spontaneous 
reversions to cephalic, and that some cases of successful ECV may have turned 
spontaneously without intervention, our finding is consistent with the literature. The ECV 
success rate in the POP study was considerably lower than reported elsewhere in the 
literature; it was even lower than the 32% success rate which has been reported as the 
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threshold level for when ECV is preferred to no intervention at all.[48] This might partly reflect 
the participants in the POP study; they were older and more likely to be obese than in many 
previous studies, and the cohort consisted of nulliparous women, who have higher rates of 
ECV failure than parous women.[9,49,50] It is also possible that the real world ECV success 
rate is lower than in the literature due to publication bias. However, sensitivity analysis 
indicates that the impact from an increased ECV success rate would be modest (an increase 
in ECV success rate by 10 percentage points lowers the incremental cost of universal 
ultrasound by £0.91 per patient). 
The findings from this study cannot easily be transferred to another health system due to the 
differences in healthcare costs and antenatal screening routines. Some countries, e.g. France 
and Germany, already offer a third trimester routine ultrasound scan. However, these scans 
are offered prior to 36 weeks’ gestational age and, as many preterm breech presentations 
revert spontaneously, it would have limited predictive value for breech at term.[51] Whether 
screening for breech presentation in lower income settings is likely to be cost effective largely 
depends on the coverage of the health-care system: whilst screening may be relatively more 
costly, the benefits from avoiding undiagnosed breech presentation may also be relatively 
larger. 
Whether the findings of this study could be extrapolated beyond nulliparous women is hard to 
assess. The absence of comparable data on screening sensitivity without universal ultrasound 
for parous women is an important limitation. The risks associated with breech birth also differ 
between nulliparous and parous women.[52,53] Compared to nulliparous women, parous 
women have higher success rates for ECV, but also higher risk of spontaneous reversion to 
breech after 36wkGA.[9,28] Also, the risks associated with vaginal breech delivery are lower 
in women who have had a previous vaginal birth.[30]  
Breech presentation is not the only complication that could be detected through late-
pregnancy ultrasound screening. The same ultrasound session could also be used to screen 
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for other indicators of fetal health such as biometry and signs of growth restriction. Whether 
also scanning for other complications could increase the benefits from universal ultrasound 
has been and currently is subject to research.[54,55] Exploring the consequences from such 
joint screening strategies goes beyond the scope of this paper but has important implications 
for policy-makers and should therefore be subject to further research. 
Conclusion 
This study shows that implementation of universal late pregnancy ultrasound to assess fetal 
presentation would virtually eliminate undiagnosed intrapartum breech presentation in 
nulliparous women. If this procedure could be implemented into routine care, for example, by 
midwives conducting a routine 36wkGA appointment and using a portable ultrasound system, 
it is likely to be cost-effective. Such a programme would be expected to reduce the 
consequences to the child of undiagnosed breech presentation; including morbidity and 
mortality. 
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